COMPREHENSIVE REVIEW OF FACTORS IMPLICATED IN THE HETEROGENEITY OF RESPONSE IN DEPRESSION: Review: Heterogeneity in Depression

Carter, Gebra Cuyún, Cantrell, Ronald A, Victoria Zarotsky, Haynes, Virginia S, Phillips, Glenn, Alatorre, Carlos I, Goetz, Iris, Paczkowski, Rosirene, Marangell, Lauren B·2012·Depression and Anxiety
DOI 10.1002/da.21918

Cited by (109)

Items 101–109 of 109

  1. Chapter 1. A Neural Circuit–Informed Taxonomy For Precision Psychiatry
    Laura M. Hack, Tali Manber Ball, Leanne Maree Williams · 2021 · American Psychiatric Association Publishing eBooks
  2. Chapter 14. Preparing For The Future Of Precision Psychiatry: The Critical Role of Neuroscience Education
    David A. Ross, Joseph J. Cooper, Melissa R. Arbuckle, Ashley E. Walker, Michael J. Travis · 2021 · American Psychiatric Association Publishing eBooks
  3. Music listening according to the iso principle in patients with mood disorders
    Katrin Starcke, Stefan Gebhardt, Richard von Georgi · 2026 · Psychology of Music
  4. Is pharmacotherapy guideline concordance consistent across patients who received pragmatic treatment for major depressive disorder?
    Mason Breitzig, Fan He, Lan Kong, Guodong Liu, Daniel A. Waschbusch, Jeff D. Yanosky, Erika F.H. Saunders, Duanping Liao · 2026 · International Journal of Psychiatry in Clinical Practice
  5. Cumulative depressive burden, functional impairment, depressive symptomatology and treatment response in Major Depressive Disorder: results from the STAR∗D and GSRD studies
    Maria Luca, Paolo Olgiati, Antonina Luca, Siegfried F. Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Panagiotis P. Ferentinos, Dan Rujescu, Raffaella Zanardi et al. · 2026 · Journal of Psychiatric Research
  6. Association of the C-1019G (rs6295) Polymorphism of the 5-HT1A Receptor Gene, Sociodemographic Variables, and Clinical Characteristics with Depressive Symptoms in a Mexican Population
    M. Hernández-Mixteco, Olga Lidia Valenzuela, Hanna Belen Baranda-Jiménez, Ricardo Jiovanni Soria-Herrera, M. Carmen, Paola Castillo-Juárez, K. Domínguez-González, O. Villavicencio-Carrisoza, Moisés León-Juárez, A. Helguera-Repetto et al. · 2026 · Diseases
  7. Association between CYP2D6 genotype and treatment effectiveness and safety in 99 hospitalized patients with major depressive disorder a retrospective cohort study CYP2D6 genotype and antidepressant response
    Aleksandra Petković-Ćurčin, Aleksandra Jeremić, Danilo Joković, Gordana Šupić, Katarina Simić, F. Milosavljević, Zvezdana Stojanović, Marin M. Jukić · 2026 · The Pharmacogenomics Journal
  8. Using point allocation to identify outcomes that matter: results from two cognitive behavioural therapy trials for depression
    Niamh Molloy, Hannah Fabian, Ailbhe Madigan, Anna Mitchell, Max Moser, Katherine Barrett, Rachel Hill, Kyriaki Michailidou, Huajie Jin, Til Wykes · 2026 · The British Journal of Psychiatry
  9. Fatores associados aos desfechos clínicos com o uso de metilfenidato em adultos com transtorno de déficit de atenção/hiperatividade (TDAH)
    Marcelo Moraes Victor · 2014 · Americanae (AECID Library)